XORTX Therapeutics (XRTX) Retained Earnings (2020 - 2026)
XORTX Therapeutics (XRTX) posted Retained Earnings of -$24.6 million for Q1 2026, down 3.39% on a QoQ basis from -$23.8 million in Q4 2025, and down 12.65% year-over-year from -$28.2 million in Q1 2025.
XORTX Therapeutics (XRTX) Retained Earnings (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Retained Earnings history runs 7 years deep, the most recent figure standing at -$24.6 million for Q1 2026.
- Quarterly Retained Earnings fell 12.65% year-over-year to -$24.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.6 million (down 12.65% YoY) and the FY2025 annual result came in at -$23.8 million, down 45189.53% from the prior year.
- Retained Earnings was -$24.6 million for Q1 2026 at XORTX Therapeutics, down from -$23.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$52605.0 in Q4 2024 and bottomed at -$24.6 million in Q1 2026.
- A 5-year average of -$17.8 million and a median of -$20.6 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings jumped 99.71% — and 2025, when it tumbled 45189.53%.
- XORTX Therapeutics' Retained Earnings stood at -$14.1 million in 2022, then slipped by 26.39% to -$17.9 million in 2023, then soared by 99.71% to -$52605.0 in 2024, then tumbled by 45189.53% to -$23.8 million in 2025, then slipped by 3.39% to -$24.6 million in 2026.
- Business Quant data shows XRTX's Retained Earnings at -$24.6 million in Q1 2026, -$23.8 million in Q4 2025, and -$23.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - | -24.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.63 Mn |
| Dec 31, 2025 | -23.82 Mn |
| Sep 30, 2025 | -23.23 Mn |
| Jun 30, 2025 | -22.58 Mn |
| Mar 31, 2025 | -21.87 Mn |
| Dec 31, 2024 | -52,605.00 |
| Sep 30, 2024 | -21.29 Mn |
| Jun 30, 2024 | -20.70 Mn |
| Mar 31, 2024 | -20.87 Mn |
| Dec 31, 2023 | -17.85 Mn |
| Sep 30, 2023 | -20.55 Mn |
| Jun 30, 2023 | -19.22 Mn |
| Mar 31, 2023 | -17.53 Mn |
| Dec 31, 2022 | -14.13 Mn |
| Sep 30, 2022 | -12.47 Mn |
| Jun 30, 2022 | -11.53 Mn |
| Mar 31, 2022 | -10.35 Mn |
| Dec 31, 2021 | -7.69 Mn |
| Sep 30, 2021 | -14.92 Mn |
| Dec 31, 2020 | -6.17 Mn |